Science Advances publishes proteomics technology from Oblique Therapeutics AB

(Oblique Therapeutics) Oblique Therapeutics AB, a Sweden-based biotech company, in collaboration with Karolinska Institutet (Stockholm, Sweden), Gothenburg University (Sweden) and several local biotechs published promising research results in the highly-acclaimed scientific journal Science Advances (AAAS) entitled: Rational Antibody design for Undruggable Targets using Kinetically Controlled Biomolecular probes.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news